HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sven-Olof Olofsson Selected Research

oxidized low density lipoprotein

9/2009ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan.
10/2007Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase.
8/2006Hypoxia converts human macrophages into triglyceride-loaded foam cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sven-Olof Olofsson Research Topics

Disease

9Insulin Resistance
01/2017 - 09/2005
6Atherosclerosis
05/2012 - 02/2002
5Type 2 Diabetes Mellitus (MODY)
01/2017 - 06/2006
3Hypoxia (Hypoxemia)
07/2011 - 08/2006
3Cardiovascular Diseases (Cardiovascular Disease)
09/2009 - 09/2003
2Dyslipidemias (Dyslipidemia)
09/2011 - 07/2008
2Ischemia
07/2011 - 12/2009
2Myocardial Infarction
07/2011 - 02/2002
1Inflammation (Inflammations)
11/2011
1Reperfusion Injury
12/2009
1Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2008
1Hypercholesterolemia
02/2002

Drug/Important Bio-Agent (IBA)

8LipidsIBA
11/2011 - 02/2002
7Proteins (Proteins, Gene)FDA Link
01/2017 - 09/2003
5Fatty Acids (Saturated Fatty Acids)IBA
11/2011 - 08/2006
3SNARE Proteins (SNAREs)IBA
01/2017 - 11/2007
3Insulin (Novolin)FDA Link
11/2011 - 06/2006
3Lipoproteins (Lipoprotein)IBA
07/2011 - 10/2007
3Messenger RNA (mRNA)IBA
01/2010 - 08/2006
3Apolipoproteins B (ApoB)IBA
09/2009 - 01/2007
3oxidized low density lipoproteinIBA
09/2009 - 08/2006
2Triglycerides (Triacylglycerol)IBA
05/2012 - 08/2006
2VLDL LipoproteinsIBA
07/2008 - 06/2006
2LDL Lipoproteins (beta Lipoproteins)IBA
10/2007 - 06/2006
1Pattern Recognition ReceptorsIBA
11/2011
1Toll-Like Receptors (Toll-Like Receptor)IBA
11/2011
1IsotopesIBA
09/2011
1VLDL receptorIBA
07/2011
1AntibodiesIBA
07/2011
1ElementsIBA
07/2011
1ImmunophilinsIBA
12/2009
1tacrolimus binding protein 1BIBA
12/2009
1UbiquitinIBA
12/2009
1MyoglobinIBA
12/2009
1Tacrolimus Binding Protein 1A (FKBP12)IBA
12/2009
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
09/2009
1Apolipoprotein C-IIIIBA
09/2009
1BiglycanIBA
09/2009
1low density lipoprotein inhibitorIBA
09/2009
1Lipid Droplet Associated ProteinsIBA
10/2008
1Oleic Acid (Oleate)IBA
11/2007
1Proteoglycans (Proteoglycan)IBA
10/2007
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
10/2007
1ApolipoproteinsIBA
10/2007
1Apolipoproteins AIBA
01/2007
1Coenzyme A Ligases (Acid-Thiol Ligases)IBA
08/2006
1EnzymesIBA
08/2006
1Acyl-CoA Dehydrogenase (Medium-Chain Acyl-Coenzyme A Dehydrogenase)IBA
08/2006
1stearoyl-coenzyme A (stearoyl-CoA)IBA
08/2006
1HDL LipoproteinsIBA
06/2006
1Lipase (Acid Lipase)FDA Link
09/2003
1Aryldialkylphosphatase (Paraoxonase)IBA
09/2003
1Amyloid (Amyloid Fibrils)IBA
09/2003
1Scavenger Receptors (Scavenger Receptor)IBA
09/2003
1Metoprolol (Toprol-XL)FDA LinkGeneric
02/2002
1Adrenergic Agents (Adrenergic Drugs)IBA
02/2002
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2002

Therapy/Procedure

1Therapeutics
02/2002